23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections

Necrotizing Soft Tissue Infections (NSTI / Necrotizing Fasciitis)

Necrotizing soft tissue infections (NSTIs) represent aggressive, rapidly destructive infections involving the skin, subcutaneous fat, and superficial and deep fascial planes. Without hyperacute surgical intervention and directed antimicrobial therapy, NSTIs carry a mortality rate exceeding 30% to 50%.

Microbiological Classification

                  NSTI MICROBIOLOGICAL CLASSIFICATION

  ┌─────────────────────────────────┐  ┌─────────────────────────────────┐
  │   TYPE I: POLYMICROBIAL (70-80%)│  │  TYPE II: MONOMICROBIAL (15-20%)│
  ├─────────────────────────────────┤  ├─────────────────────────────────┤
  │ • Mixture: Anaerobes + Aerobes  │  │ • Group A Streptococcus (GAS)   │
  │   (Bacteroides, Clostridium,    │  │   (Streptococcus pyogenes)      │
  │    Peptostreptococcus PLUS      │  │ • With/without S. aureus (MRSA) │
  │    E. coli, Klebsiella, Proteus)│  │ • Any age; healthy young hosts  │
  │ • Elderly, Diabetics, PVD       │  │ • Blunt trauma, lacerations, IVDU│
  │ • Fournier Gangrene (Perineum)  │  │ • Severe Toxic Shock Syndrome   │
  └─────────────────────────────────┘  └─────────────────────────────────┘

1. Type I (Polymicrobial):
   • Represents 70% to 80% of all NSTI cases.
   • Microbiology: Synergistic mixture of obligate anaerobes (Bacteroides fragilis, Clostridium perfringens, Peptostreptococcus) and facultative Gram-negative aerobic bacilli (Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis) or enterococci.
   • Host Risk Factors: Poorly controlled diabetes mellitus, peripheral vascular disease, chronic kidney disease, obesity, malnutrition, and postoperative or decubitus wound breakdown.
   • Fournier Gangrene: A specific Type I polymicrobial necrotizing fasciitis of the male or female perineum, scrotum, and perianal region. Often originates from an occult perirectal abscess, urethral stricture, or minor cutaneous abrasion. Spreads rapidly along Colles, Dartos, and Scarpa fascial planes.
2. Type II (Monomicrobial):
   • Represents 15% to 20% of cases.
   • Microbiology: Group A Streptococcus (Streptococcus pyogenes / GAS), either alone or co-infecting with Staphylococcus aureus (including community-acquired MRSA).
   • Host Risk Factors: Can occur in any age group, including previously healthy, immunocompetent children and young adults. Often precipitated by minor blunt non-penetrating trauma (muscle hematoma), insect bites, surgical incisions, childbirth, or intravenous drug use.
   • Virulence: GAS strains express virulent surface M-proteins and release pyrogenic exotoxins (SPE-A, SPE-B, SPE-C), frequently triggering concurrent Streptococcal Toxic Shock Syndrome (STSS) with profound capillary leak, multiorgan failure, and refractory shock.
3. Type III (Marine / Waterborne):
   • Monomicrobial infection caused by Vibrio vulnificus or Aeromonas hydrophila. Associated with open wound exposure to warm seawater, brackish water, or handling raw marine oysters, especially in patients with chronic liver disease, hemochromatosis, or cirrhosis (iron overload markedly accelerates Vibrio proliferation).
4. Type IV (Fungal):
   • Zygomycetes (Mucor, Rhizopus, Lichtheimia) or Candida species, occurring predominantly in immunocompromised, neutropenic, or severe burn patients.

Pathophysiological Progression

Bacteria enter subcutaneous planes, producing bacterial enzymes (hyaluronidase, collagenase, heparinase, streptokinase) that rapidly hydrolyze fascial matrices. Infection spreads horizontally along the relatively hypovascular deep fascia at rates exceeding 1 inch per hour without initially involving the overlying muscular layers or epidermis. As fascial inflammation surges:

1. Endothelial destruction triggers diffuse microvascular thrombosis of the nutrient perforating cutaneous arterioles that traverse the deep fascia to supply the overlying skin.
2. Overlying skin and subcutaneous tissues undergo acute ischemia, evolving into liquefactive necrosis ("dishwater pus").
3. Cutaneous nerve branches are destroyed, producing localized dermal anesthesia.

Clinical Manifestations: Early vs. Late Signs

• The Earliest & Most Sensitive Hallmark: Pain out of proportion to physical examination findings. The patient complains of excruciating, unbearable pain, yet physical examination may initially reveal only mild, ill-defined erythema and soft tissue swelling without obvious skin breakdown.
• Pain extending significantly beyond the visible borders of cutaneous erythema.
• Centrifugal Progression: The erythematous and indurated border visibly expands over a matter of hours. Marking the erythema border with a surgical pen reveals rapid migration outside the lines.
• Late Signs (Diagnostic of Advanced Tissue Death):
  • Transition of skin color from bright red to dusky, bronze, violaceous, or gray-black patchiness;
  • Tense bullae containing hemorrhagic, serosanguinous, or foul-smelling fluid;
  • Cutaneous anesthesia: The previously excruciatingly painful area becomes completely numb to pinprick due to thrombotic necrosis of cutaneous nerves;
  • Soft-tissue crepitus: Palpable crackling beneath the skin caused by gas production from anaerobic bacterial fermentation. Critical Board Pearl: Crepitus is a prominent sign in Type I polymicrobial / clostridial infections, but is completely absent in pure Type II monomicrobial Streptococcus pyogenes infections (GAS does not produce gas!);
  • Systemic septic shock, tachypnea, high fever or hypothermia, delirium, and multiorgan failure.

---

The LRINEC Score: Clinical Value and Critical Board Pitfall

The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score was developed to help differentiate severe cellulitis from necrotizing fasciitis based on six routine laboratory parameters:

Scoring Interpretation & The Fatal Pitfall

• Score ≤5: Low risk (<50% probability).
• Score 6 to 7: Intermediate risk (suspicious for NSTI).
• Score ≥8: High risk (>75% strongly predictive probability of NSTI).
• THE CRITICAL BOARD PEARL: While a high LRINEC score (≥6 to 8) strongly raises suspicion for necrotizing fasciitis, a low or normal LRINEC score (<6) NEVER excludes NSTI! Meta-analyses indicate that the clinical sensitivity of the LRINEC score is only 68% to 80%. Approximately one out of every five patients with surgically confirmed necrotizing fasciitis presents with a LRINEC score <6 (particularly young patients, early presenters, and immunocompromised hosts). Waiting for laboratory tests or imaging studies when clinical signs suggest NSTI represents catastrophic malpractice.

---

Emergency Management of Necrotizing Soft Tissue Infections

                      EMERGENCY NSTI MANAGEMENT

  ┌─────────────────────────────────────────────────────────────┐
  │ STEP 1: IMMEDIATE SURGICAL CONSULTATION FOR OR EXPLORATION │
  │ • Surgery is the ONLY definitive diagnostic & therapeutic  │
  │   intervention; do NOT delay for imaging or labs!           │
  │ • Bedside "Finger Test" if operating room is delayed        │
  ├─────────────────────────────────────────────────────────────┤
  │ STEP 2: EMPIRIC TRIPLE INTRAVENOUS ANTIMICROBIAL REGIMEN    │
  │ • VANCOMYCIN 15-20 mg/kg IV q8-12h (covers MRSA) PLUS       │
  │ • PIPERACILLIN-TAZOBACTAM 3.375-4.5g IV q6h OR MEROPENEM 1g │
  │   (covers Gram-negative bacilli and anaerobes) PLUS         │
  │ • CLINDAMYCIN 600-900 mg IV q8h                             │
  │   (shuts down 50S ribosomal toxin synthesis; Eagle effect)  │
  ├─────────────────────────────────────────────────────────────┤
  │ STEP 3: AGGRESSIVE ICU RESUSCITATION & REPEAT OR DEBRIDEMENT│
  │ • 30 mL/kg balanced crystalloids + vasopressors             │
  │ • Mandatory planned second-look OR debridement in 24-48 hrs │
  └─────────────────────────────────────────────────────────────┘

1. Emergent Operative Debridement

• Surgical intervention is the single definitive therapy for necrotizing fasciitis. A delay to operative debridement exceeding 6 to 12 hours results in an exponential increase in mortality.
• Operative Findings: Incision reveals grayish, necrotic deep fascia, absence of normal bleeding along fascial planes, lack of resistance to blunt finger dissection, and thin, foul-smelling exudate ("dishwater pus"). Radical debridement of all non-viable skin, subcutaneous fat, and fascia must be carried out to healthy, bleeding tissue.
• The Bedside "Finger Test": In an equivocal case where surgical access is delayed, infiltrate local lidocaine, make a 2-cm incision down to the deep fascia, and gently probe with an index finger. If the subcutaneous tissue separates effortlessly from the deep fascia with minimal resistance and no bleeding, the diagnosis of necrotizing fasciitis is confirmed.

2. The Empiric Triple Antimicrobial Regimen

Empiric antimicrobial coverage must immediately be initiated while the operating room is mobilized:

1. Vancomycin (15 to 20 mg/kg IV every 8 to 12 hours) to cover methicillin-resistant Staphylococcus aureus (MRSA);
2. Piperacillin-tazobactam (3.375 g to 4.5 g IV every 6 hours) OR Meropenem (1 g IV every 8 hours) to provide comprehensive coverage against Gram-negative enteric bacilli and anaerobes;
3. Clindamycin (600 mg to 900 mg IV every 8 hours).

Clindamycin Pharmacology & The Eagle Effect

Why is clindamycin mandatory when broad-spectrum beta-lactams are already administered?

• 50S Ribosomal Toxin Suppression: Clindamycin is a lincosamide antibiotic that binds specifically to the 50S ribosomal subunit, halting bacterial protein translation. By blocking protein synthesis, clindamycin immediately shuts down the synthesis and secretion of lethal bacterial exotoxins, including toxic shock syndrome toxin-1 (TSST-1), streptococcal pyrogenic exotoxins (SPE-A, SPE-B, SPE-C), and antiphagocytic M-protein.
• The "Eagle Effect" (Inoculum Effect):
  • In severe, deep necrotizing infections with high bacterial densities, bacteria rapidly enter a stationary growth phase.
  • Beta-lactam antibiotics (penicillins, cephalosporins, carbapenems) require active cell wall synthesis and high expression of penicillin-binding proteins (PBPs) to exert their bactericidal activity. In high-inoculum stationary-phase infections, PBPs are dramatically downregulated, causing beta-lactams to lose their bactericidal efficacy (the Eagle effect).
  • Clindamycin acts independently of bacterial growth phase and cell wall synthesis, maintaining potent ribosomal suppression and clinical efficacy even in dense, stationary-phase inocula.

---

Severe Central Nervous System Infections: Acute Bacterial Meningitis

Acute bacterial meningitis is an emergent infection of the subarachnoid space associated with significant morbidity, permanent neurological sequelae, and mortality rates of 15% to 25% in adults.

Common Microbial Pathogens Across Demographics

• Streptococcus pneumoniae (Pneumococcus): The most frequent cause of bacterial meningitis in adults of all ages (~50% to 60%). Characterized by high mortality (~20%) and severe neurological sequelae (sensorineural hearing loss in up to 30%). Associated with concurrent pneumonia, acute otitis media, mastoiditis, sinusitis, asplenia, or basilar skull fractures with CSF leak.
• Neisseria meningitidis (Meningococcus): Common in adolescents, young adults, college dormitories, and military barracks. Also elevated in patients with terminal complement deficiencies (C5-C9) or those treated with eculizumab. Hallmark feature is a rapid petechial or purpuric rash on the trunk and extremities, which can progress to purpura fulminans, bilateral adrenal hemorrhage, and cardiovascular collapse (Waterhouse-Friderichsen syndrome).
• Listeria monocytogenes: A motile, facultative intracellular Gram-positive rod. Accounts for up to 20% of meningitis in adults ≥50 years of age, pregnant women, alcoholics, and immunocompromised hosts (e.g., solid organ transplant, hematologic malignancy, corticosteroid therapy). Transmitted via ingestion of contaminated unpasteurized milk, soft cheeses, and processed deli meats. Critical Board Pearl: Listeria is intrinsically resistant to all cephalosporins!

Clinical Presentation

• The Classic Triad: Fever, altered mental status, and neck stiffness (nuchal rigidity). Board Fact: The complete triad is present in only approximately 44% of adult patients. However, >95% of patients present with at least two of the following four signs: headache, fever, neck stiffness, and altered mental status.
• Meningeal Signs:
  • Nuchal Rigidity: Inability to flex the neck forward passively to touch the chin to the sternum due to reflex paraspinal muscle spasm.
  • Kernig Sign: Resistance or pain when extending the knee with the hip flexed at 90 degrees.
  • Brudzinski Sign: Involuntary flexion of the hips and knees elicited by passive flexion of the patient's neck.
  • Diagnostic Reality: Meningeal signs have high specificity (~95%) but low sensitivity (~50%); their absence never excludes meningitis.

---

Diagnostic Sequence: The Head CT Controversy

Lumbar puncture (LP) is the essential diagnostic test to confirm bacterial meningitis. However, performing an LP in the presence of an unrecognized mass lesion or elevated intracranial pressure can theoretically precipitate fatal transtentorial or tonsillar brain herniation.

                MENINGITIS DIAGNOSTIC & THERAPEUTIC SEQUENCE

    Patient Presents with Suspected Acute Bacterial Meningitis
                               │
                               ▼
                 OBTAIN BLOOD CULTURES STAT (x2)
                               │
                               ▼
     Does the patient meet ANY criteria for Head CT before LP?
     1. Immunocompromised state (HIV, chemo, transplant)
     2. History of CNS disease (stroke, mass, focal infection)
     3. New-onset seizure within 1 week
     4. Papilledema on funduscopy
     5. Abnormal level of consciousness (GCS <15)
     6. Focal neurologic deficit (cranial palsy, motor drift)
                               │
               ┌───────────────┴───────────────┐
               │ YES                           │ NO
               ▼                               ▼
   1. ADMINISTER EMPIRIC ANTIBIOTICS   PERFORM LUMBAR PUNCTURE
      PLUS DEXAMETHASONE IMMEDIATELY!  IMMEDIATELY
   2. Transport for Head CT                    │
   3. If CT normal: Lumbar Puncture            ▼
               │                       ADMINISTER EMPIRIC ANTIBIOTICS
               │                       PLUS DEXAMETHASONE STAT
               └───────────────┬───────┘
                               ▼
                 CSF ANALYSIS & TARGETED THERAPY

The 6 Evidence-Based Indications for Head CT Prior to LP

According to the Infectious Diseases Society of America (IDSA) guidelines, a screening non-contrast Head CT is indicated prior to LP only if one or more of the following 6 criteria are present:

1. Immunocompromised state (known HIV/AIDS, active chemotherapy, post-organ transplant, high-dose corticosteroids);
2. History of central nervous system (CNS) disease (prior stroke, brain tumor, intracerebral hemorrhage, focal brain abscess);
3. New-onset seizure within 1 week of presentation;
4. Papilledema on funduscopic examination (loss of venous pulsations alone is insufficient);
5. Abnormal level of consciousness (Glasgow Coma Scale <15, lethargy, stupor, or coma);
6. Focal neurologic deficit (e.g., asymmetric cranial nerve palsy, hemiparesis, asymmetric motor drift, aphasia).

THE CRITICAL CLINICAL RULE

If a patient meets criteria for a screening Head CT prior to LP:

• BLOOD CULTURES MUST BE DRAWN IMMEDIATELY, and
• EMPIRIC INTRAVENOUS ANTIMICROBIALS PLUS DEXAMETHASONE MUST BE ADMINISTERED BEFORE SENDING THE PATIENT TO THE CT SCANNER!
• Never withhold or delay antibiotic administration to wait for neuroimaging. Each hour of delay in antibiotic administration significantly increases hospital mortality and permanent brain damage. CSF opening pressure, protein, glucose, and cell counts remain diagnostic for several hours after antibiotic administration, and CSF bacterial PCR and antigen testing remain positive even after bacterial cultures become sterilized.

---

Cerebrospinal Fluid (CSF) Analysis & Interpretation

---

Empiric Antimicrobial Regimens & Corticosteroid Protocol

1. Age-Based Empiric Antimicrobial Regimens

• Adults Aged 18 to 49 Years:
  • Ceftriaxone 2 g IV every 12 hours (or Cefotaxime 2 g IV every 4 to 6 hours) PLUS
  • Vancomycin 15 to 20 mg/kg IV every 8 to 12 hours (target trough 15 to 20 mcg/mL).
  • Rationale: Ceftriaxone provides bactericidal coverage against N. meningitidis and susceptible S. pneumoniae. Vancomycin is added to cover cephalosporin-resistant S. pneumoniae.
• Adults Aged ≥50 Years OR Immunocompromised Hosts:
  • Ceftriaxone 2 g IV every 12 hours PLUS
  • Vancomycin 15 to 20 mg/kg IV every 8 to 12 hours PLUS
  • Ampicillin 2 g IV every 4 hours.
  • Rationale: Ampicillin is mandatory to cover Listeria monocytogenes, which possesses low-affinity penicillin-binding proteins that render it inherently resistant to third-generation cephalosporins.
• Severe Beta-Lactam / Cephalosporin Anaphylaxis:
  • Vancomycin 15-20 mg/kg IV q8-12h PLUS Moxifloxacin 400 mg IV q24h PLUS Trimethoprim-sulfamethoxazole (TMP-SMX) 5 mg/kg IV q8h (to cover Listeria).

2. Adjunctive Corticosteroid Protocol: Dexamethasone

• Dose & Regimen: IV Dexamethasone 10 mg (or 0.15 mg/kg) administered prior to or concurrently with the first dose of antimicrobials, continued at 10 mg IV every 6 hours for 4 days.
• Mechanism: Antimicrobial-induced bacterial lysis releases cell wall components (peptidoglycan, teichoic acid, endotoxin) into the subarachnoid space, triggering an intense burst of inflammatory cytokines (TNF-alpha, IL-1). Dexamethasone attenuates this inflammatory burst, reducing cerebral edema, intracranial pressure, and neuronal damage.
• Clinical Benefit: The landmark European Dexamethasone Trial demonstrated that early dexamethasone significantly reduced mortality and prevented permanent sensorineural hearing loss in adults with Streptococcus pneumoniae meningitis.
• Timing Rule: Corticosteroids must be administered before or with the first antibiotic dose. If antibiotics have already been administered, starting dexamethasone hours later provides no survival benefit. If CSF analysis or culture confirms an organism other than S. pneumoniae, dexamethasone should be discontinued (though IDSA guidelines permit continuation if Haemophilus influenzae is identified).

3. Post-Exposure Chemoprophylaxis for Close Contacts

Chemoprophylaxis is indicated for close contacts of patients with confirmed or suspected Neisseria meningitidis (household members, dorm roommates, day-care contacts, or healthcare providers exposed to respiratory secretions during endotracheal intubation):

1. Rifampin: 600 mg PO twice daily for 2 days (4 total doses); OR
2. Ciprofloxacin: 500 mg PO as a single dose (first-line in adults, unless fluoroquinolone resistance is documented); OR
3. Ceftriaxone: 250 mg IM as a single dose (preferred agent in pregnant women).